MARCKSL1 and leukocyte adhesion deficiency: Our research elucidated the inhibitory role of MARCKSL1–2/SUZ12/HDAC1/miR-200b axis in the growth and DTX resistance of LAD cells, suggesting that MARCKSL1–2 could be a promising target to improve the chemotherapy of LAD patients.